Ischemic heart disease decisions — 2026

The Veteran's claims for increased ratings for valvular heart disease, peripheral vascular disease of the right and left legs, and hypertension were denied. The Board found that the evidence did not support higher ratings under the applicable rating criteria.

The Board denied service connection for diabetes mellitus, prostate cancer, ischemic heart disease, right lower extremity peripheral artery disease, left lower extremity peripheral artery disease, and hypertension as the evidence did not establish an in-service event or exposure to herbicide agents.

The Board granted service connection for ischemic heart disease based on presumed herbicide exposure from qualifying Vietnam service.

The Veteran's current coronary artery disease with acute, subacute, or old myocardial infarction with coronary stent is being remanded for further evaluation due to the lack of a medical nexus between his service-connected hypertension and his heart condition.

The Veteran's claim for a heart disability prior to his death is granted as he was entitled to accrued benefits due to the September 1994 claim, which included ischemic heart disease, a covered herbicide disease.

The Board denied the Veteran's claim for SMC based on aid and attendance from June 1, 2011, to May 24, 2017, finding that his need for regular aid and attendance was not established during this period.

The Veteran's claims for an earlier effective date for service connection and TDIU are remanded due to the need for additional medical opinions regarding the etiology of his coronary artery disease.

The Veteran's claims for service connection and increased ratings for various conditions, including left knee, right knee, left shoulder, right shoulder, and coronary artery disease, have been denied. The Board found no evidence linking these disabilities to the Veteran's active duty.

The Board denied service connection for coronary artery disease, hypertension, and stroke as there was no evidence of herbicide agent exposure during service and the medical opinions were against a nexus to service.

The Board has granted service connection for obstructive sleep apnea and heart disability, including coronary artery disease, as these conditions are found to be proximately due to or the result of the Veteran's service-connected PTSD.

The Board granted a 30 percent rating for coronary heart disease effective February 10, 2021. The Veteran's condition did not meet the criteria for an earlier effective date or increased rating.

The Veteran's service connection claim for coronary artery disease with myocardial infarction is granted on a presumptive basis due to exposure to herbicide agents during his active duty in Korea.

The Veteran's claim for special monthly compensation based on aid and attendance (SMC AA) is remanded due to a duty to assist error. The VA needs to obtain an examination to assess the Veteran's need for aid and attendance.

The Board has granted service connection for prostate cancer, coronary artery disease (CAD), diabetes mellitus type II (DM II), hypertension, and erectile dysfunction as secondary to service-connected DM II. The Veteran's exposure to Agent Orange during active service is presumed.

The Veteran's appeal for a higher rating for right foot disability status post Mitchell's bunionectomy is granted with an effective date of July 25, 2023.,The Veteran's appeal for a higher rating for left foot disability status post Mitchell's bunionectomy is dismissed as it does not meet the criteria for an earlier effective date.

The Veteran's claims for service connection for hypertension, diabetes, heart disease, and kidney disease are being remanded due to the need for VA examinations to determine if these conditions are related to his exposure to contaminants in the water supply at Camp Lejeune during service.

The Board has remanded the Veteran's claims for service connection due to errors in obtaining relevant medical records and authorization for private treatment providers. The issues include heart disorder, OSA, sinusitis, lumbar spine disorder, and right knee disorder all related to Agent Orange exposure.

The Board has remanded the claims for service connection for left toe amputation, triple bypass surgery, blockage in legs, and bilateral tinnitus due to procedural errors and the need for additional medical opinions regarding potential exposure to toxins during service.

The Veteran's arteriosclerotic heart disease is rated at 100% effective October 25, 2024. His prostate cancer residuals are rated at 60% effective October 25, 2024.

The Veteran's claim for an increased rating for coronary artery disease is being remanded due to the inadequacy of a previous VA examination.